Materialise NV (MTLS)
| Market Cap | 330.77M +8.9% |
| Revenue (ttm) | 308.46M -0.7% |
| Net Income | 11.61M +8.2% |
| EPS | 0.20 +7.9% |
| Shares Out | 58.44M |
| PE Ratio | 28.87 |
| Forward PE | 34.64 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 69,731 |
| Open | 5.71 |
| Previous Close | 5.87 |
| Day's Range | 5.61 - 5.76 |
| 52-Week Range | 4.78 - 6.80 |
| Beta | 1.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 7, 2026 |
About MTLS
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and c... [Read more]
Financial Performance
In 2025, Materialise NV's revenue was 267.63 million, an increase of 0.33% compared to the previous year's 266.77 million. Earnings were 7.72 million, a decrease of -42.56%.
Financial numbers in EUR Financial StatementsNews
Materialise Reports First Quarter 2026 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, to...
Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, t...
Materialise to Transfer RapidFit Business to Its Management Team
Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing softw...
Materialise NV Earnings Call Transcript: Q4 2025
Revenue grew 6.8% in Q4 2025, with strong medical segment growth offsetting manufacturing declines. 2026 guidance anticipates continued double-digit medical growth, stable software, and ongoing manufacturing headwinds, with adjusted EBIT expected at EUR 10–12 million.
Materialise Reports Fourth Quarter and Full Year 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and se...
Materialise NV to Report Fourth Quarter 2025 Earnings on Thursday, February 19, 2026
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, t...
Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, t...
Materialise to pursue additional listing on Euronext Brussels
Materialise (MTLS) announced its plans to pursue an additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares represen...
Materialise to Hold Extraordinary Shareholders' Meeting on November 14, 2025
LEUVEN, Belgium, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it ...
Materialise to Pursue Additional Listing on Euronext Brussels and Potential ADS Buyback Program
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announ...
Materialise NV Earnings Call Transcript: Q3 2025
Q3 2025 saw strong double-digit growth in the medical segment, offsetting declines in software and manufacturing due to macroeconomic headwinds. Gross margin remained robust at 56.8%, and guidance for FY 2025 was maintained, with confidence in future growth as market conditions improve.
Materialise Reports Third Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a global leader in 3D-printed medical devices and software and a pioneer in additive manufacturing software and services, today announce...
Materialise NV to Report Third Quarter 2025 Earnings on Tuesday, October 28, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise NV Earnings Call Transcript: Q2 2025
Q2 2025 saw strong double-digit growth in the medical segment, offset by declines in software and manufacturing due to macroeconomic and FX headwinds. Revenue guidance for the year was slightly reduced, but profitability guidance was maintained, with cost control and strategic investments supporting resilience.
Materialise lowers 2025 revenue view to EUR265M-EUR280M
06:40 EDT Materialise (MTLS) lowers 2025 revenue view to EUR265M-EUR280M
Materialise reports Q2 EPS EUR0.0 vs. EUR0.07 last year
Reports Q2 revenue EUR64.83M vs. EUR68.8M last year. CEO Brigitte de Vet-Veithen commented, “Our Materialise (MTLS) Medical segment once again demonstrated its resilience, growing by almost 17% compar...
Materialise Reports Second Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financi...
Materialise NV to Report Second Quarter 2025 Earnings on Thursday, July 24, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025
LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it w...
Materialise NV Earnings Call Transcript: Q1 2025
Revenue grew 4% year-over-year in Q1 2025, led by strong medical segment growth, while software and manufacturing faced headwinds. Net loss was EUR 0.5 million due to FX impacts, but cash flow remained strong. Full-year guidance is maintained despite expected Q2 challenges.
Materialise Reports First Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financi...
Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise NV Earnings Call Transcript: Q4 2024
2024 saw 4% revenue growth and stable adjusted EBIT despite macroeconomic headwinds, with strong performance in medical and aerospace offset by weakness in manufacturing and automotive. 2025 guidance anticipates continued growth in medical and software, but ongoing challenges in manufacturing due to European market conditions.
Materialise reports Q4 EPS EUR0.05 vs. (EUR0.01) last year
Reports Q4 revenue EUR65.68M from EUR65.30M last year. CEO Brigitte de Vet-Veithen commented, “In the final quarter of 2024 our Materialise (MTLS) Medical segment continued on its growth path, again
Materialise Reports Fourth Quarter and Full Year 2024 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced i...